Clinical Trial on Entocid Chewable Tablet for Hyperacidity and Gastroesophageal Reflex Disease

Objective: To investigate the therapeutic effects of the herbal medication Entocid chewable Tablet a product of Herbion pharmaceutical on the indications and gastric motility of patients with hyperacidity and gastro esophageal reflux disease (GERD). Methods: Total 50 patient were selected for this study. The patients were selected using a modified Reflux Disease Questionnaire, which is a validated, self-administered scale that is widely used for the assessment of anti-reflux treatment effects. Patients were advised to take study medicine 2 tablets twice daily after meal for 1 week. We take follow up after 1 week. We select the subjects from Sharafi Goth Govt. Hospital Naik Muhamamd Dispensary. Results: Entocid Chewable tablets were innocuous and well endured and compact the occurrences of all the evaluated GERD symptoms, with no adverse events requiring withdrawal. Conclusion: Entocid chewable tablets may provide a harmless and active management for decreasing the symptoms of GERD.